tiprankstipranks
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
US Market

NLS Pharmaceutics (NLSP) Technical Analysis

155 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
NLS Pharmaceutics’s (NLSP) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting NLS Pharmaceutics is a Sell.
NLS Pharmaceutics’s (NLSP) 20-Day exponential moving average is 0.18, while NLS Pharmaceutics’s (NLSP) share price is $0.202, making it a Buy.
NLS Pharmaceutics’s (NLSP) 50-Day exponential moving average is 0.18, while NLS Pharmaceutics’s (NLSP) share price is $0.202, making it a Buy.

NLS Pharmaceutics (NLSP) Pivot Points

Jul 04, 2024, 04:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.11
0.15
0.18
0.21
0.24
0.28
0.30
Fibonacci
0.15
0.18
0.19
0.21
0.24
0.25
0.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NLS Pharmaceutics (NLSP) Moving Averages

Jul 04, 2024, 04:18 PM
Period
Simple
Exponential
MA5
0.21Sell
0.20Sell
MA10
0.20Buy
0.19Buy
MA20
0.17Buy
0.18Buy
MA50
0.16Buy
0.18Buy
MA100
0.22Sell
0.24Sell
MA200
0.39Sell
0.42Sell
NLS Pharmaceutics’s (NLSP) 10-Day exponential moving average is 0.19, while NLS Pharmaceutics’s (NLSP) share price is $0.202, making it a Buy.
NLS Pharmaceutics’s (NLSP) 100-Day exponential moving average is 0.24, while NLS Pharmaceutics’s (NLSP) share price is $0.202, making it a Sell.
NLS Pharmaceutics’s (NLSP) stock price is $0.202 and NLS Pharmaceutics’s (NLSP) 50-day simple moving average is 0.16, creating a Buy signal.
NLS Pharmaceutics’s (NLSP) stock price is $0.202 and NLS Pharmaceutics’s (NLSP) 100-day simple moving average is 0.22, creating a Sell signal.
NLS Pharmaceutics’s (NLSP) stock price is $0.202 and NLS Pharmaceutics’s (NLSP) 200-day simple moving average is 0.39, creating a Sell signal.

NLS Pharmaceutics (NLSP) Technical Indicators

Jul 04, 2024, 04:18 PM
Name
Value
Implied Action
RSI (14)
55.14
Neutral
STOCH (9,6)
15.90
Buy
STOCHRSI (14)
25.36
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
42.71
Neutral
Williams %R
-74.64
Buy
CCI (14)
43.56
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
37.48
Neutral
ROC
66.67
Buy
NLS Pharmaceutics’s (NLSP) Relative Strength Index (RSI) is 55.14, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Trend Strength Indicator (ADX) is 42.71, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Commodity Channel Index (CCI) is 43.56, creating a Neutral signal.
NLS Pharmaceutics’s (NLSP) Price Rate of Change (ROC) is 66.67, creating a Buy signal.

FAQ

Is NLSP a Buy, Hold, or Sell?
Based on NLSP’s technical indicators, NLSP is a Buy.
    What is NLSP’s RSI (14)?
    NLSP’s RSI (14) is 55.14, which suggests NLSP is a Neutral.
      What is NLSP’s MACD?
      NLSP’s MACD is 0.02, which suggests NLSP is a Sell.
        What is NLSP’s 5-day moving average?
        NLSP’s 5-day moving average is 0.21, which suggests NLSP is a Sell.
          What is NLSP’s 20-day moving average?
          NLSP 20-day moving average is 0.17, which suggests NLSP is a Buy.
            What is NLSP’s 50-day moving average?
            NLSP’s 50-day moving average is 0.16, which suggests NLSP is a Buy.
              What is NLSP’s 200-day moving average?
              NLSP’s 200-day moving average is 0.39, which suggests NLSP is a Sell.
                What is NLSP’s Williams % R (14)?
                NLSP’s Williams % R (14) is -74.64, which suggests NLSP is a Buy.
                  What is NLSP’s CCI (14)?
                  NLSP’s CCI (14) is 43.56, which suggests NLSP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis